To find the role of Guduchi,Amalaki and Tejpatra in Diabetes mellitus patients

Evaluate the efficacy of Guduchi , Amalaki and Tejpatra churna in disintegration of pathogenesis in various Prakriti of Madhumehi patients-Randomized parallel Group trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053863

Enrollment

100

Registered

2023-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Fasting blood sugar greater than or equal to 126 mg/dl 2. Patients with Post prandial blood sugar greater than 200 mg/dl and less than 350 mg/dl 3. Patients with classical sign and symptoms of Type 2 Diabetes mellitus 4. Patients with HbA1c greater than 6.4% and less than 10% 5.Newly diagnosed patients (within one year). 6.Patients willing to provide consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers 2. Patients with Type 1 Diabetes mellitus 3. Patients with serious hepatic,cardiac or renal disorders. 4. Drug induced serious illness

Design outcomes

Primary

Measure	Time frame
1. The hypoglycaemic effect of Guduchi , Amalaki and Tejpatra churna. 2.The The hypoglycaemic effect of Guduchi , Amalaki and Tejpatra churna according to the dominant Prakriti. Timepoint: day 0, day 14,day 28,day 45	—

Secondary

Measure	Time frame
The study will provide cost effective , safe ayurvedic drug with minimal or no side effectsTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Kanchan S Nagre

Chaudhary Brahm Prakash Ayurved Charak Sansthan

umeshsapra123@gmail.com8588943505

Outcome results